Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2001 2
2002 2
2003 2
2004 6
2005 1
2006 3
2007 2
2008 7
2009 5
2010 5
2011 8
2012 11
2013 11
2014 14
2015 11
2016 9
2017 14
2018 5
2019 8
2020 7
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Results by year
Filters applied: . Clear all
Page 1
Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells.
Zhu X, Badawi M, Pomeroy S, Sutaria DS, Xie Z, Baek A, Jiang J, Elgamal OA, Mo X, Perle K, Chalmers J, Schmittgen TD, Phelps MA. Zhu X, et al. Among authors: phelps ma. J Extracell Vesicles. 2017 Jun 6;6(1):1324730. doi: 10.1080/20013078.2017.1324730. eCollection 2017. J Extracell Vesicles. 2017. PMID: 28717420 Free PMC article.
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
Saygin C, Larkin K, Blachly JS, Orwick S, Ngankeu A, Gregory CT, Phelps MA, Mani S, Walker A, Garzon R, Vasu S, Walsh KJ, Bhatnagar B, Klisovic RB, Grever MR, Marcucci G, Byrd JC, Blum W, Mims AS. Saygin C, et al. Among authors: phelps ma. Am J Hematol. 2020 Dec;95(12):1457-1465. doi: 10.1002/ajh.25958. Epub 2020 Sep 19. Am J Hematol. 2020. PMID: 32777116 Free PMC article. Clinical Trial.
Population pharmacokinetics of lenalidomide in patients with B-cell malignancies.
Hughes JH, Phelps MA, Upton RN, Reuter SE, Gao Y, Byrd JC, Grever MR, Hofmeister CC, Marcucci G, Blum W, Blum KA, Foster DJR. Hughes JH, et al. Among authors: phelps ma. Br J Clin Pharmacol. 2019 May;85(5):924-934. doi: 10.1111/bcp.13873. Epub 2019 Feb 27. Br J Clin Pharmacol. 2019. PMID: 30672004 Free PMC article.
Phase I study of AR-42 and decitabine in acute myeloid leukemia.
Liva SG, Coss CC, Wang J, Blum W, Klisovic R, Bhatnagar B, Walsh K, Geyer S, Zhao Q, Garzon R, Marcucci G, Phelps MA, Walker AR. Liva SG, et al. Among authors: phelps ma. Leuk Lymphoma. 2020 Jun;61(6):1484-1492. doi: 10.1080/10428194.2020.1719095. Epub 2020 Feb 8. Leuk Lymphoma. 2020. PMID: 32037935 Clinical Trial.
Discovery of Anticancer Agents of Diverse Natural Origin.
Kinghorn AD, DE Blanco EJ, Lucas DM, Rakotondraibe HL, Orjala J, Soejarto DD, Oberlies NH, Pearce CJ, Wani MC, Stockwell BR, Burdette JE, Swanson SM, Fuchs JR, Phelps MA, Xu L, Zhang X, Shen YY. Kinghorn AD, et al. Among authors: phelps ma. Anticancer Res. 2016 Nov;36(11):5623-5637. doi: 10.21873/anticanres.11146. Anticancer Res. 2016. PMID: 27793884 Free PMC article. Review.
Rituximab immunotherapy: it's getting personal.
Phelps MA. Phelps MA. Blood. 2017 May 11;129(19):2595-2596. doi: 10.1182/blood-2017-03-772061. Blood. 2017. PMID: 28495922 Free article. No abstract available.
125 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page